Fujifilm launches a more comprehensive portfolio for Europe's healthcare community following the integration of Hitachi Diagnostic Imaging

Healthshare Group Choose Fujifilm’s DXA Solution Community Trial

Roche Italia and Fujifilm Italia join forces to reprioritise breast health with the “screening routine” campaign 

Fujifilm Launches Highly-Sensitive and Rapid Covid-19 Antigen Test

Fujifilm Healthcare Digital Tour: Leading radiology services out of COVID-19

Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream

Launch of Therapeutic Radiopharmaceutical Product, Lutathera^® Injection targeting neuroendocrine tumors in Japan  (FUJIFILM Toyama Chemical)

$850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity

Marketing Authorization Granted for Lutathera^® Injection in Japan
- The first approval in Japan for peptide receptor radionuclide treatment drug, providing a new therapeutic option for neuroendocrine tumors  (FUJIFILM Toyama Chemical)

Fujifilm sets its highest record with 23 products winning the internationally prestigious “iF Design Award”